Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03653481 · ClinicalTrials.gov registry record · NA
Treating IBD With Inulin
A NA study, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- NA
- Development phase
- 51
- Enrollment target
NCT03653481 is a NA study that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 51 participants.
The verdict
NCT03653481, a NA study, has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- NA
- Development phase
- 51 participants
- Enrollment target
Study Summary
The purpose of this study is to see how the prebiotic inulin changes the gut bacteria (microbiome) of children and young adults with IBD and determine if this dietary intervention can help reduce disease activity.
Interventions
- DIETARY_SUPPLEMENT Maltodextrin
- DIETARY_SUPPLEMENT Oligofructose-enriched Inulin OI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2018-10-29 |
| Est. Completion | 2022-08-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03653481
The ClinicalTrials.gov registry entry for NCT03653481 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Maltodextrin is the first listed.
NCT03653481 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03653481 about?
NCT03653481 is a clinical study titled "Treating IBD With Inulin". The purpose of this study is to see how the prebiotic inulin changes the gut bacteria (microbiome) of children and young adults with IBD and determine if this dietary intervention can help reduce disease activity.
What is the current status of trial NCT03653481?
This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2018-10-29. Estimated completion is 2022-08-30.
What interventions are being tested in trial NCT03653481?
The interventions under investigation include: Maltodextrin (DIETARY_SUPPLEMENT), Oligofructose-enriched Inulin OI (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03653481?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.